129 related articles for article (PubMed ID: 22126285)
1. Novel cancer drugs based on epigenetics, miRNAs and their interactions.
Roukos DH
Epigenomics; 2011 Dec; 3(6):675-8. PubMed ID: 22126285
[No Abstract] [Full Text] [Related]
2. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
3. Global epigenetic profiling in bladder cancer.
Dudziec E; Goepel JR; Catto JW
Epigenomics; 2011 Feb; 3(1):35-45. PubMed ID: 22126151
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
Cacabelos R
Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
[TBL] [Abstract][Full Text] [Related]
5. What is the potential of epigenetics in drug development?
Lundstrom K
Future Med Chem; 2015; 7(3):239-42. PubMed ID: 25826357
[No Abstract] [Full Text] [Related]
6. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions.
Lin J; Wang C; Kelly WK
Semin Oncol; 2013 Jun; 40(3):393-401. PubMed ID: 23806502
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic code in depression: implications for treatment.
Schroeder M; Hillemacher T; Bleich S; Frieling H
Clin Pharmacol Ther; 2012 Feb; 91(2):310-4. PubMed ID: 22205200
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
10. A chemical epigenetics approach for engineering the in situ biosynthesis of a cryptic natural product from Aspergillus niger.
Henrikson JC; Hoover AR; Joyner PM; Cichewicz RH
Org Biomol Chem; 2009 Feb; 7(3):435-8. PubMed ID: 19156306
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
13. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
Bar-Sela G; Jacobs KM; Gius D
Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
[TBL] [Abstract][Full Text] [Related]
14. Advances in the computational development of DNA methyltransferase inhibitors.
Medina-Franco JL; Caulfield T
Drug Discov Today; 2011 May; 16(9-10):418-25. PubMed ID: 21315180
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and epigenetics.
Sato F; Tsuchiya S; Meltzer SJ; Shimizu K
FEBS J; 2011 May; 278(10):1598-609. PubMed ID: 21395977
[TBL] [Abstract][Full Text] [Related]
16. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapies reach main street.
Bates SE
Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
[No Abstract] [Full Text] [Related]
19. Making bad cells go good: the promise of epigenetic therapy.
Sausville EA; Carducci MA
J Clin Oncol; 2005 Jun; 23(17):3875-6. PubMed ID: 15946932
[No Abstract] [Full Text] [Related]
20. DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy.
Brueckner B; Lyko F
Trends Pharmacol Sci; 2004 Nov; 25(11):551-4. PubMed ID: 15491775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
